Non-contrast transcatheter aortic valve implantation for patients with aortic stenosis and chronic kidney disease: a pilot study

被引:4
|
作者
Freire, Antonio Fernando Diniz [1 ]
Nicz, Pedro Felipe Gomes [1 ]
Ribeiro, Henrique Barbosa [1 ]
Filippini, Filippe Barcellos [1 ]
Accorsi, Tarso Duenas [1 ]
Liberato, Gabriela [1 ]
Nomura, Cesar Higa [1 ]
Cassar, Renata de Sa [1 ]
Vieira, Marcelo Luiz Campos [1 ]
Mathias Jr, Wilson [1 ]
Pomerantzeff, Pablo Maria Alberto [1 ]
Tarasoutchi, Flavio [1 ]
Abizaid, Alexandre [1 ]
Kalil Filho, Roberto [1 ]
de Brito Jr, Fabio Sandoli [1 ]
机构
[1] Univ Sao Paulo InCor, Dept Intervent Cardiol, Heart Inst, Sao Paulo, Brazil
来源
关键词
transcatheter aortic valve replacement; aortic stenosis; renal failure; zero contrast; renal insufficiency; OUTCOMES; INJURY; REPLACEMENT; PREDICTORS; IMPACT;
D O I
10.3389/fcvm.2023.1175600
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAcute kidney injury (AKI) is frequently observed after transcatheter aortic valve implantation (TAVI). Of note, it is associated with a threefold increase in all-cause and cardiac death. We propose a new non-contrast strategy for evaluating and performing the TAVI procedure that can be especially valuable for patients with aortic stenosis (AS) and chronic kidney disease (CKD) to prevent AKI. MethodsPatients with severe symptomatic AS and CKD stage & GE;3a were evaluated for TAVI using four non-contrast imaging modalities for procedural planning: transesophageal echocardiogram (TEE), cardiac magnetic resonance, multidetector computed tomography (MDCT), and aortoiliac CO2 angiography. Patients underwent transfemoral (TF) TAVI using the self-expandable Evolut R/Pro, and the procedures were guided by fluoroscopy and TEE. Contrast MDCT and contrast injection at certain checkpoints during the procedure were used in a blinded fashion to guarantee patient safety. ResultsA total of 25 patients underwent TF-TAVI with the zero-contrast technique. The mean age was 79.9 & PLUSMN; 6.1 years, 72% in NYHA class III/IV, with a mean STS-PROM of 3.0% & PLUSMN; 1.5%, and creatinine clearance of 49 & PLUSMN; 7 ml/min. The self-expandable Evolut R and Pro were implanted in 80% and 20% of patients, respectively. In 36% of the cases, the transcatheter heart valve (THV) chosen was one size larger than the one by contrast MDCT, but none of these cases presented adverse events. Device success and the combined safety endpoint (at 30 days) both achieved 92%. Pacemaker implantation was needed in 17%. ConclusionThis pilot study demonstrated that the zero-contrast technique for procedural planning and THV implantation was feasible and safe and might become the preferable strategy for a significant population of CKD patients undergoing TAVR. Future studies with a larger number of patients are still needed to confirm such interesting findings.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Transcatheter aortic valve implantation in patients with pre-existing chronic kidney disease
    Rahman, Mohammed Shamim
    Sharma, Rajan
    Brecker, Stephen J. D.
    IJC HEART & VASCULATURE, 2015, 8 : 9 - 18
  • [32] Transcatheter aortic valve implantation for severe aortic stenosis
    Garg, Ankit
    Verma, Subodh
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (05) : E134 - E134
  • [33] Aortic stenosis and transcatheter aortic valve implantation in the elderly
    Rayner, Clare
    Adams, Heath
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2023, 52 (07) : 458 - 463
  • [34] Coronary Artery Disease in Patients with Aortic Stenosis and Transcatheter Aortic Valve Implantation: Implications for Management
    de Azevedo Filho, Antonio F. B.
    Accorsi, Tarso A. D.
    Ribeiro, Henrique B.
    EUROPEAN CARDIOLOGY REVIEW, 2021, 16
  • [35] Feasibility and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis
    Pontnau, F.
    Himbert, D.
    Messika-Zeitoun, D.
    Detaint, D.
    Cueff, C.
    Laissy, J. -P.
    Sordi, M.
    Descoutures, F.
    Nataf, P.
    Vahanian, A.
    EUROPEAN HEART JOURNAL, 2012, 33 : 581 - 581
  • [36] EFFICACY OF TRANSCATHETER AORTIC VALVE IMPLANTATION FOR SEVERE AORTIC VALVE STENOSIS IN HEMODIALYSIS PATIENTS
    Nakagaki, Masahiro
    Harada, Kenji
    Kanai, Hidetoshi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I838 - I838
  • [37] Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Small Aortic Annulus
    Kalavrouziotis, Dimitri
    Rodes-Cabau, Josep
    Bagur, Rodrigo
    Doyle, Daniel
    De Larochelliere, Robert
    Pibarot, Philippe
    Dumont, Eric
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (10) : 1016 - 1024
  • [38] Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Small Aortic Annulus
    Kalavrouziotis, Dimitri
    Doyle, Daniel
    Rodes-Cabau, Josep
    Bagur, Rodrigo
    DeLarochelliere, Robert
    Pibarot, Philippe
    Dumont, Eric
    CIRCULATION, 2010, 122 (21)
  • [39] Prognostic value of acute kidney injury after transcatheter aortic valve implantation in patients with aortic stenosis
    Munoz-Garcia, E.
    Munoz-Garcia, M.
    Garcia, A. J. Munoz
    Dominguez-Franco, A. J.
    Jimenez-Navarro, M. F.
    Alonso-Briales, J. H.
    Hernandez-Garcia, J. M.
    Gomez-Doblas, J. J.
    De Teresa-Galvan, E.
    EUROPEAN HEART JOURNAL, 2016, 37 : 81 - 81
  • [40] TEE-Guided Transcatheter Aortic Valve Implantation With "Zero Contrast" - A Viable Alternative for Patients with Chronic Kidney Disease
    Pershad, Ashish
    Fraij, Ghassan
    Girotra, Sudhakar V.
    Fang, H. Kenith
    Gellert, George
    JOURNAL OF INVASIVE CARDIOLOGY, 2015, 27 (02): : E25 - E26